scispace - formally typeset
E

Ellen Triantafellow

Researcher at Novartis

Publications -  13
Citations -  5037

Ellen Triantafellow is an academic researcher from Novartis. The author has contributed to research in topics: Autophagy & PI3K/AKT/mTOR pathway. The author has an hindex of 8, co-authored 13 publications receiving 4491 citations.

Papers
More filters
Journal ArticleDOI

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

TL;DR: It is shown that cellular uptake of L-glutamine and its subsequent rapid efflux in the presence of essential amino acids (EAA) is the rate-limiting step that activates mTOR.
Journal ArticleDOI

Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1

TL;DR: It is demonstrated that mTORC1 activation is sufficient to stimulate specific metabolic pathways, including glycolysis, the oxidative arm of the pentose phosphate pathway, and de novo lipid biosynthesis, through the activation of a transcriptional program affecting metabolic gene targets of hypoxia-inducible factor and sterol regulatory element-binding protein.

Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1

Abstract: Aberrant activation of the mammalian target of rapamycin complex 1 (mTORC1) is a common molecular event in a variety of pathological settings, including genetic tumor syndromes, cancer, and obesity. However, the cell-intrinsic consequences of mTORC1 activation remain poorly defined. Through a combination of unbiased genomic, metabolomic, and bioinformatic approaches, we demonstrate that mTORC1 activation is sufficient to stimulate specific metabolic pathways, including glycolysis, the oxidative arm of the pentose phosphate pathway, and de novo lipid biosynthesis. This is achieved through the activation of a transcriptional program affecting metabolic gene targets of hypoxia-inducible factor (HIF1alpha) and sterol regulatory element-binding protein (SREBP1 and SREBP2). We find that SREBP1 and 2 promote proliferation downstream of mTORC1, and the activation of these transcription factors is mediated by S6K1. Therefore, in addition to promoting protein synthesis, mTORC1 activates specific bioenergetic and anabolic cellular processes that are likely to contribute to human physiology and disease.
Journal ArticleDOI

Relieving Autophagy and 4EBP1 from Rapamycin Resistance

TL;DR: It is shown that the ability of rapamycin to activate autophagy in different cell lines correlates with mTORC1 stability and that knockdown of raptor relieves Autophagy and the eIF4E effector pathway fromRapamycin resistance.